David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.83% |
| 2 | Healthcare | 10.76% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Financials | 8.43% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
1751
PUT
DELISTED
Comerica
CMA
| $2.83M | ﹤0.01% |
29,500
-48,100
| -62% | -$4.59M |
|
|
VIVO
1752
DELISTED
Meridian Bioscience Inc
VIVO
| $2.83M | ﹤0.01% |
199,207
+25,574
| +15% | +$378K |
|
1753
Nu Skin
NUS
$236M
| $2.83M | ﹤0.01% |
+38,332
| New | +$2.72M |
|
|
PRFT
1754
DELISTED
Perficient Inc
PRFT
| $2.82M | ﹤0.01% |
123,005
-16,101
| -12% | -$334K |
|
1755
CALL
Cognex
CGNX
$10.1B
| $2.82M | ﹤0.01% |
54,200
| – | – |
|
|
KTWO
1756
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.82M | ﹤0.01% |
148,621
-13,697
| -8% | -$271K |
|
1757
V2X
VVX
$2.4B
| $2.81M | ﹤0.01% |
75,521
+25,330
| +50% | +$820K |
|
1758
Collegium Pharmaceutical
COLL
$852M
| $2.81M | ﹤0.01% |
109,972
-117,300
| -52% | -$2.79M |
|
1759
PUT
D.R. Horton
DHI
$42.2B
| $2.81M | ﹤0.01% |
+64,100
| New | +$2.99M |
|
1760
Oceaneering
OII
$4.97B
| $2.81M | ﹤0.01% |
151,341
-15,823
| -9% | -$317K |
|
1761
CALL
Darden Restaurants
DRI
$25B
| $2.81M | ﹤0.01% |
32,900
+15,600
| +90% | +$1.48M |
|
1762
Bath & Body Works
BBWI
$3.54B
| $2.8M | ﹤0.01% |
90,765
-250,673
| -73% | -$9.48M |
|
1763
Adient
ADNT
$1.44B
| $2.8M | ﹤0.01% |
46,816
-189,042
| -80% | -$12.6M |
|
1764
PUT
LGI Homes
LGIH
$1.37B
| $2.79M | ﹤0.01% |
39,600
-17,200
| -30% | -$1.16M |
|
1765
Cerus
CERS
$548M
| $2.79M | ﹤0.01% |
509,997
-158,598
| -24% | -$721K |
|
1766
Atkore
ATKR
$3.16B
| $2.79M | ﹤0.01% |
140,680
+18,642
| +15% | +$401K |
|
1767
NMI Holdings
NMIH
$3.41B
| $2.79M | ﹤0.01% |
168,630
-52,485
| -24% | -$977K |
|
1768
CALL
Puma Biotechnology
PBYI
$481M
| $2.79M | ﹤0.01% |
41,000
| – | – |
|
1769
National Health Investors
NHI
$3.6B
| $2.79M | ﹤0.01% |
41,414
+25,479
| +160% | +$1.74M |
|
1770
TG Therapeutics
TGTX
$8.48B
| $2.78M | ﹤0.01% |
195,524
+107,253
| +122% | +$1.37M |
|
1771
PUT
Albemarle
ALB
$15.7B
| $2.77M | ﹤0.01% |
29,900
+9,900
| +50% | +$1.09M |
|
|
1772
Darden Restaurants
DRI
$25B
| $2.77M | ﹤0.01% |
32,461
-45,538
| -58% | -$4.31M |
|
1773
SM Energy
SM
$8.49B
| $2.77M | ﹤0.01% |
153,462
-265,998
| -63% | -$5.75M |
|
1774
Digi International
DGII
$2.88B
| $2.77M | ﹤0.01% |
268,531
-9,516
| -3% | -$98.8K |
|
|
CSW
1775
CSW Industrials
CSW
$5.26B
| $2.75M | ﹤0.01% |
61,159
-428
| -0.7% | -$19.9K |
|
Similar funds
David Shaw's Q1 2018 Portfolio in Review
As of Q1 2018, David Shaw held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- David Shaw added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- David Shaw's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- David Shaw fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- David Shaw's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- David Shaw opened 451 new positions and closed 554 in Q1 2018.
- David Shaw's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.